Urmăriți
Stephen J Nicholls
Stephen J Nicholls
Adresă de e-mail confirmată pe monash.edu
Titlu
Citat de
Citat de
Anul
Cardiovascular and renal outcomes with empagliflozin in heart failure
M Packer, SD Anker, J Butler, G Filippatos, SJ Pocock, P Carson, ...
New England Journal of Medicine 383 (15), 1413-1424, 2020
37542020
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European …
BA Ference, HN Ginsberg, I Graham, KK Ray, CJ Packard, E Bruckert, ...
European heart journal 38 (32), 2459-2472, 2017
31812017
Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial
SE Nissen, SJ Nicholls, I Sipahi, P Libby, JS Raichlen, CM Ballantyne, ...
Jama 295 (13), 1556-1565, 2006
29992006
Empagliflozin in heart failure with a preserved ejection fraction
SD Anker, J Butler, G Filippatos, JP Ferreira, E Bocchi, M Böhm, ...
New England Journal of Medicine 385 (16), 1451-1461, 2021
27612021
Effects of dalcetrapib in patients with a recent acute coronary syndrome
GG Schwartz, AG Olsson, M Abt, CM Ballantyne, PJ Barter, J Brumm, ...
New England Journal of Medicine 367 (22), 2089-2099, 2012
22482012
Antiinflammatory properties of HDL
PJ Barter, S Nicholls, KA Rye, GM Anantharamaiah, M Navab, ...
Circulation research 95 (8), 764-772, 2004
16832004
Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials
AM Lincoff, K Wolski, SJ Nicholls, SE Nissen
Jama 298 (10), 1180-1188, 2007
16512007
Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis
M Jun, C Foote, J Lv, B Neal, A Patel, SJ Nicholls, DE Grobbee, A Cass, ...
The Lancet 375 (9729), 1875-1884, 2010
11902010
Effect of torcetrapib on the progression of coronary atherosclerosis
SE Nissen, JC Tardif, SJ Nicholls, JH Revkin, CL Shear, WT Duggan, ...
New England Journal of Medicine 356 (13), 1304-1316, 2007
11572007
Effect of two intensive statin regimens on progression of coronary disease
SJ Nicholls, CM Ballantyne, PJ Barter, MJ Chapman, RM Erbel, P Libby, ...
New England Journal of Medicine 365 (22), 2078-2087, 2011
10982011
Effect of evolocumab on progression of coronary disease in statin-treated patients: the GLAGOV randomized clinical trial
SJ Nicholls, R Puri, T Anderson, CM Ballantyne, L Cho, JJP Kastelein, ...
Jama 316 (22), 2373-2384, 2016
10802016
Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European …
J Boren, MJ Chapman, RM Krauss, CJ Packard, JF Bentzon, CJ Binder, ...
European heart journal 41 (24), 2313-2330, 2020
10322020
Comparison of pioglitazone vs glimepiride on progression of coronary atherosclerosis in patients with type 2 diabetes: the PERISCOPE randomized controlled trial
SE Nissen, SJ Nicholls, K Wolski, R Nesto, S Kupfer, A Perez, H Jure, ...
Jama 299 (13), 1561-1573, 2008
10022008
Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis
SJ Nicholls, EM Tuzcu, I Sipahi, AW Grasso, P Schoenhagen, T Hu, ...
Jama 297 (5), 499-508, 2007
9732007
Myeloperoxidase and cardiovascular disease
SJ Nicholls, SL Hazen
Arteriosclerosis, thrombosis, and vascular biology 25 (6), 1102-1111, 2005
9552005
Protein carbamylation links inflammation, smoking, uremia and atherogenesis
Z Wang, SJ Nicholls, ER Rodriguez, O Kummu, S Hörkkö, J Barnard, ...
Nature medicine 13 (10), 1176-1184, 2007
7812007
Evacetrapib and cardiovascular outcomes in high-risk vascular disease
AM Lincoff, SJ Nicholls, JS Riesmeyer, PJ Barter, HB Brewer, KAA Fox, ...
New England Journal of Medicine 376 (20), 1933-1942, 2017
7222017
Effect of high-dose omega-3 fatty acids vs corn oil on major adverse cardiovascular events in patients at high cardiovascular risk: the STRENGTH randomized clinical trial
SJ Nicholls, AM Lincoff, M Garcia, D Bash, CM Ballantyne, PJ Barter, ...
Jama 324 (22), 2268-2280, 2020
6532020
Relationship of paraoxonase 1 (PON1) gene polymorphisms and functional activity with systemic oxidative stress and cardiovascular risk
T Bhattacharyya, SJ Nicholls, EJ Topol, R Zhang, X Yang, D Schmitt, X Fu, ...
Jama 299 (11), 1265-1276, 2008
6462008
Association of triglyceride-lowering LPL variants and LDL-C–lowering LDLR variants with risk of coronary heart disease
BA Ference, JJP Kastelein, KK Ray, HN Ginsberg, MJ Chapman, ...
Jama 321 (4), 364-373, 2019
5712019
Sistemul nu poate realiza operația în acest moment. Încercați din nou mai târziu.
Articole 1–20